ALLR Allarity Therapeutics Inc
Price (delayed)
$0.9101
Market cap
$15.49M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.65
Enterprise value
-$2.7M
Highlights
Allarity Therapeutics's EPS has shrunk by 100% QoQ but it has surged by 100% YoY
Allarity Therapeutics's net income has shrunk by 106% YoY and by 31% QoQ
Allarity Therapeutics's quick ratio has decreased by 28% QoQ
Key stats
What are the main financial stats of ALLR
Market
Valuations
Earnings
Shares outstanding
17.01M
Market cap
$15.49M
Enterprise value
-$2.7M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.34
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$27.24M
Net income
-$24.52M
EBIT
-$24.24M
EBITDA
-$24.23M
Free cash flow
-$17.65M
Per share
Balance sheet
Liquidity
EPS
-$15.65
EPS diluted
-$15.65
Free cash flow per share
-$10.98
Book value per share
$2.66
Revenue per share
$0
TBVPS
$14.09
Total assets
$22.65M
Total liabilities
$10.84M
Debt
$1.35M
Equity
$11.81M
Working capital
$11.5M
Debt to equity
0.11
Current ratio
2.06
Quick ratio
1.8
Net debt/EBITDA
0.75
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-117.2%
Return on equity
-263.8%
Return on invested capital
N/A
Return on capital employed
-205.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ALLR stock price
How has the Allarity Therapeutics stock price performed over time
Intraday
-2.86%
1 week
-18.01%
1 month
13.95%
1 year
-99.43%
YTD
-22.21%
QTD
-2.86%
Financial performance
How have Allarity Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$27.24M
Net income
-$24.52M
Gross margin
N/A
Net margin
N/A
Allarity Therapeutics's net income has shrunk by 106% YoY and by 31% QoQ
ALLR's operating income has dropped by 59% year-on-year and by 10% since the previous quarter
Growth
What is Allarity Therapeutics's growth rate over time
Valuation
What is Allarity Therapeutics stock price valuation
P/E
N/A
P/B
0.34
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Allarity Therapeutics's EPS has shrunk by 100% QoQ but it has surged by 100% YoY
ALLR's equity is down by 9% from the previous quarter
Efficiency
How efficient is Allarity Therapeutics business performance
Allarity Therapeutics's ROA has increased by 26% YoY but it has decreased by 13% from the previous quarter
ALLR's ROE is up by 20% QoQ
Dividends
What is ALLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ALLR.
Financial health
How did Allarity Therapeutics financials performed over time
ALLR's total assets is 109% more than its total liabilities
ALLR's total assets has soared by 91% YoY and by 11% from the previous quarter
Allarity Therapeutics's total liabilities has increased by 46% from the previous quarter but it has decreased by 26% YoY
The company's debt is 89% lower than its equity
ALLR's debt to equity has surged by 123% year-on-year and by 10% since the previous quarter
ALLR's equity is down by 9% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.